Achondroplasia is the most common skeletal dysplasia and is characterized by a variety of medical, functional and psychosocial challenges across the lifespan. There is variability in…
Read More
Despite the recognized expertise of pediatric endocrinologists, children with skeletal dysplasias have not been consistently managed by these physicians. Growth-altering treatments have broadened the role of…
Read More
Achondroplasia growth charts included in this article. Achondroplasia is the most common genetic skeletal disorder causing disproportionate short stature/dwarfism. Common additionalfeatures include spinal stenosis, midface retrusion,…
Read More
These treatment pathways were developed by the type 2 diabetes subgroup of the PES Diabetes SIG, using evidence base when available in combination with expert clinical…
Read More
The prevalence of obesity and associated comorbidities is rising. This material summarized the anti-obesity medications adapted by the PES Obesity Special Interest Group from the original…
Read More
This is a perspective that very briefly summarizes the evidence at that time of publication for treatment of youth-onset type 2 diabetes, as well as some…
Read More
The Department of Defense revised its regulations on medical qualification for military service, effective November 16th, 2022. The DSD-SIG and Board of PES supported efforts for…
Read More